New Delhi: Yashoda Super Specialty HospitalKaushambi announced his collaboration with haystackanalyticsto bring the latest in technology genomic solutions Right to the comfort of the homes of consumers in Delhi NCR.
the strategic camaraderie aims to provide the city with unprecedented access to diagnosis capabilities. With the advent of advanced technology and the growing concern for prevention health careHaystackAnalytics has empowered the doctors at Yashoda Super Specialty Hospital, Kaushambi, to extend their reach beyond the confines of traditional hospital settings and deliver advanced medical care, diagnostics and consultation services directly to consumers’ homes.
Dr PN Arora, CMD, Yashoda Super Specialty Hospital, Kaushambi said, “We are excited to partner with HaystackAnalytics to bring preventative genomics directly to our patients.”
Dr. Anirvan Chatterjee, CEO of HaystackAnalytics, said: “These collaborations allow HaystackAnalytics to showcase the growing acceptance and preference of genomics for primary and preventative healthcare. After the successful launch of the first comprehensive trial of genomics-based preventative healthcare solution in Mumbai in collaboration with Wockhardt Hospital and Godrej Memorial Hospital, we are now paving our way to the capital through various collaborations, to Yashoda Hospital , the pioneers in healthcare. services. Together, we can unlock the immense potential of genomics for the benefit of patients.”
Smart Gene Plan is a fully automated AI-based bioinformatics platform used to create consumer-focused wellness products. The program aims to provide individuals with a personalized circuit view of preventive health care, including early identification of potential future health problems through pathology and genetic studies. It is the first genomic test of its kind for preventive health care that examines the whole exome, the initial cost of the test is Rs 21,000, covering more than 7,000 genes, nearly 9,000 mutations and significant blood parameters to determine the origin underlying. disease predispositions. Dr Upasana Arora, CEO and Director of Yashoda Super Specialty Hospital, Kaushambi, said: “In India, the need for preventative healthcare has become more critical than ever. By prioritizing preventative measures, we can proactively address health issues, promote wellness, and create a healthier nation. And by harnessing the power of genomics, we will be able to gain insight to understand valuable information about an individual’s genetic predispositions, allowing for personalized preventative strategies.”
Addressing the meeting, Dr. Aparna Bhanushali, Head of Growth and Scientific Support at HaystackAnalytics, stated: “According to a recent report by the International Diabetes Federation, India is currently home to the largest number of people with diabetes in the world, with around 77 million, and the report also indicates that this number is projected to rise to 134 million by 2045. This is an alarming statistic that highlights the urgent need for preventative measures. Furthermore, India also witnesses a significant number of premature deaths due to cardiovascular diseases, accounting for a quarter of all deaths. This is where the Smart Gene Plan is equipped to provide a comprehensive solution to this crisis, by enabling early identification of health problems and providing necessary treatment to those who need it.”
This collaboration between Yashoda Super Specialty Hospital, Kaushambi and HaystackAnalytics marks a major step forward in integrating genomics into mainstream healthcare. By incorporating genomic data, healthcare providers will gain a deeper understanding of genetic variations, disease risks, and potential responses to treatment, leading to more personalized and effective healthcare interventions.
